CLINUVEL PHARMACEUTICALS LIMITED (CUVL) Capital expenditures 2024–2026
CLINUVEL PHARMACEUTICALS LIMITED (CUVL) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$1.1MFY2026 · since FY2024: $3.7M → $1.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $1.1M | +455.0% |
| FY2025 | $190,593 | -94.8% |
| FY2024 | $3.7M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice